The role of clinical pharmacology in the development and evaluation of oral controlled-release dosage forms.
作者信息
Kendall M J, John V A
出版信息
Br J Clin Pharmacol. 1985;19 Suppl 2(Suppl 2):65S-67S. doi: 10.1111/j.1365-2125.1985.tb02744.x.
Abstract
摘要
相似文献
1
The role of clinical pharmacology in the development and evaluation of oral controlled-release dosage forms.临床药理学在口服控释剂型研发与评价中的作用。
Br J Clin Pharmacol. 1985;19 Suppl 2(Suppl 2):65S-67S. doi: 10.1111/j.1365-2125.1985.tb02744.x.
2
Slow release beta-adrenoceptor blocking drugs.缓释β-肾上腺素能受体阻滞剂
J R Coll Physicians Lond. 1983 Apr;17(2):126-32.
3
Treatment of angina pectoris with beta-receptor blocking agents. Effects of long-term treatment and treatment with sustained release tablets.
Acta Med Scand. 1971 Apr;189(4):299-301.
4
[Treatment of angina pectoris with beta-receptor blockaders a slow-releasing isosorbide dinitrate preparation].
Schweiz Med Wochenschr. 1973 Dec 15;103(50):1789-92.
5
Mononitrates in combination with beta-blocker therapy in the treatment of severe angina pectoris.
Drugs. 1987;33 Suppl 4:122-4. doi: 10.2165/00003495-198700334-00022.
6
[Clinical significance of long-acting anti-anginal drugs in the treatment of cardiovascular diseases].
Kokyu To Junkan. 1990 Nov;38(11):1081-9.
7
8
9
Drugs for angina pectoris.
Drug Ther Bull. 1974 Jan 4;12(1):1-2.
10
Isosorbide 5-mononitrate: a review of a sustained-release formulation (Imdur) in stable angina pectoris.单硝酸异山梨酯：稳定性心绞痛缓释制剂（依姆多）综述
Drugs. 1999 Feb;57(2):261-77. doi: 10.2165/00003495-199957020-00016.
引用本文的文献
1
Controlled release metoprolol. Clinical pharmacokinetic and therapeutic implications.控释美托洛尔。临床药代动力学及治疗意义。
Clin Pharmacokinet. 1991 Nov;21(5):319-30. doi: 10.2165/00003088-199121050-00001.
本文引用的文献
1
Rate-controlled drug dosage.速率控制的药物剂量。
Drugs. 1982 Mar;23(3):207-26. doi: 10.2165/00003495-198223030-00003.
2
Drug delivery systems.药物递送系统
Pharmacol Ther. 1981;13(1):149-91. doi: 10.1016/0163-7258(81)90070-x.
Zotero 插件